Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

• Main Authors: M. Romano (Author), I. Pontikaki (Author), M. Gattinara (Author), I. Ardoino (Author), C. Donati (Author), P. Boracchi (Author), P.L. Meroni (Author), V. Gerloni (Author)
• Format: Book
• Published: PAGEPress Publications, 2014-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The objective of this study was to determine long-term effectiveness and safety of 1^st biological treatment (BT) in a cohort of 301 juvenile idiopathic arthritis (JIA) patients (pts), non-responders to disease-modifying antirheumatic drugs (DMARDs), in terms of drug survival (...